IN8BIO, Inc.
INAB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001740279
No open-market purchases or sales by IN8BIO, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $5.35M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in IN8BIO, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +5 vs. Q1 2023
- Shares held
- 2.33M
- +963.0K (+70.5%) vs. Q1 2023
- Total value
- $3.59M
- +$1.81M (+101.9%) vs. Q1 2023
- New holders
- 7
- 10 more added
- Sold out
- 2
- 4 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INAB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $5.35M |
| Q1 2026 | 19 | $5.55M |
| Q4 2025 | 22 | $7.45M |
| Q3 2025 | 19 | $2.13M |
| Q2 2025 | 12 | $1.83M |
| Q1 2025 | 28 | $3.60M |
| Q4 2024 | 26 | $7.72M |
| Q3 2024 | 26 | $2.06M |
| Q2 2024 | 26 | $6.77M |
| Q1 2024 | 32 | $10.2M |
| Q4 2023 | 30 | $11.4M |
| Q3 2023 | 21 | $2.58M |
| Q2 2023 | 22 | $3.59M |
| Q1 2023 | 17 | $1.78M |
| Q4 2022 | 16 | $2.79M |
| Q3 2022 | 17 | $2.42M |
| Q2 2022 | 15 | $5.50M |
| Q1 2022 | 14 | $7.02M |
| Q4 2021 | 14 | $7.80M |
| Q3 2021 | 13 | $12.2M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding IN8BIO, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ensign Peak Advisors, Inc | 470,028 | $723.8K | 0.00% | +400,000+571.2% | Added |
| Voss Capital, LLC | 457,876 | $705.1K | 0.09% | +119,857+35.5% | Added |
| Vanguard Group Inc | 287,567 | $442.9K | 0.00% | +77,497+36.9% | Added |
| Sigma Planning Corp | 279,400 | $430.3K | 0.02% | +75,500+37.0% | Added |
| Stonegate Investment Group, LLC | 180,000 | $277.2K | 0.01% | −52,310−22.5% | Reduced |
| Geode Capital Management, LLC | 176,561 | $271.9K | 0.00% | +118,715+205.2% | Added |
| Rock Creek Group, LP | 76,314 | $117.5K | 0.02% | −5,254−6.4% | Reduced |
| State Street Corp | 59,246 | $91.2K | 0.00% | +59,246 | New |
| Citadel Advisors LLC | 57,722 | $88.9K | 0.00% | +57,722 | New |
| Bridgeway Capital Management, LLC | 49,000 | $75.5K | 0.00% | −25,000−33.8% | Reduced |
| BlackRock Inc. | 45,091 | $69.4K | 0.00% | +12,492+38.3% | Added |
| Northern Trust Corp | 43,258 | $66.6K | 0.00% | +30,005+226.4% | Added |
| Overbrook Management Corp | 33,756 | $52.0K | 0.01% | +33,756 | New |
| Renaissance Technologies LLC | 21,700 | $33.0K | 0.00% | +21,700 | New |
| Two Sigma Investments, LP | 18,189 | $28.0K | 0.00% | +18,189 | New |
| Dimensional Fund Advisors LP | 17,583 | $27.1K | 0.00% | −6,899−28.2% | Reduced |
| Westside Investment Management, Inc. | 15,750 | $24.3K | 0.01% | +15,750 | New |
| Charles Schwab Investment Management Inc | 13,105 | $20.2K | 0.00% | +13,105 | New |
| Wells Fargo & Company | 10,167 | $15.7K | 0.00% | +41+0.4% | Added |
| HighTower Advisors, LLC | 10,000 | $15.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 6,774 | $10.4K | 0.00% | +1,890+38.7% | Added |
| Royal Bank of Canada | 263 | $0 | 0.00% | +217+471.7% | Added |
| UBS Group AG | 0 | $0 | 0.00% | −3,133−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −38−100.0% | Sold out |